{"meta":{"query_hash":"9675f88f4559","filters":{"venue":"Journal of Pharmaceutics"},"cohort_total":3,"direct_labels_cover":0,"predictions_cover":3,"exported":3,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/9675f88f4559","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+Pharmaceutics"},"results":[{"id":"W1983963892","doi":"10.1155/2013/103527","title":"Microencapsulation for the Therapeutic Delivery of Drugs, Live Mammalian and Bacterial Cells, and Other Biopharmaceutics: Current Status and Future Directions","year":2012,"lang":"en","type":"review","venue":"Journal of Pharmaceutics","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Biopharmaceutics; Drug delivery; Pharmaceutical technology; Nanotechnology; Pharmacology; Biochemical engineering; Chemistry; Medicine; Materials science; Engineering; Biochemistry; Biological activity; Pharmacognosy","score_opus":0.08625569136415033,"score_gpt":0.3801273506697642,"score_spread":0.2938716593056139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983963892","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0084824925,0.9882561,0.000024172738,0.00009191028,0.0022324962,0.0007223167,0.00016707812,0.000008951996,0.000014489843],"genre_scores_gemma":[0.002026842,0.9953014,0.00027324204,0.00012068793,0.002174157,0.000010794416,0.000010003554,0.000049301943,0.000033554774],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986189,0.00013952793,0.0006669814,0.00014200294,0.00018954638,0.0002430573],"domain_scores_gemma":[0.99810475,0.00048335988,0.0008201998,0.00011430375,0.00021237326,0.0002650291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004612703,0.00028555817,0.00090721913,0.00019852271,0.00009063791,0.000038025995,0.000058809655,0.00014826554,0.00006210641],"category_scores_gemma":[0.000017140206,0.0001726947,0.00022394699,0.00011385394,0.00015676,0.000088265966,0.000035047982,0.00044769465,9.55049e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002359347,0.000112464564,0.00014035802,0.007827131,0.0007631801,6.287619e-7,0.0007414387,1.3162698e-7,0.001452646,0.000016609203,0.00011715613,0.9885923],"study_design_scores_gemma":[0.0017711835,0.00013929479,0.00009432377,0.0012913772,0.011991806,0.000108863605,0.0003098637,0.000056647146,0.00071507524,0.000008450189,0.98336774,0.00014536476],"about_ca_topic_score_codex":0.0000034610478,"about_ca_topic_score_gemma":3.8531746e-7,"teacher_disagreement_score":0.98844695,"about_ca_system_score_codex":0.0000647175,"about_ca_system_score_gemma":0.00019120646,"threshold_uncertainty_score":0.7042285},"labels":[],"label_agreement":null},{"id":"W2016731078","doi":"10.1155/2013/365635","title":"Health Technology Assessment Fireside: Antibiotic Prophylaxis and Dental Treatment in Canada","year":2012,"lang":"en","type":"review","venue":"Journal of Pharmaceutics","topic":"Healthcare cost, quality, practices","field":"Health Professions","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Guideline; Antibiotic prophylaxis; Intensive care medicine; Context (archaeology); Population; Psychological intervention; Antibiotics; Environmental health; Nursing","score_opus":0.6977975149070008,"score_gpt":0.6418478359959107,"score_spread":0.05594967891109015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016731078","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0046023163,0.9869454,0.0000067296505,0.004012032,0.0021192033,0.0021136424,0.00009292228,0.000014113047,0.00009365546],"genre_scores_gemma":[0.022001984,0.9755915,0.0007026481,0.0009351205,0.000578631,0.000029066083,0.000011089408,0.00007009415,0.000079883685],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9898589,0.004858107,0.0032566125,0.00030522677,0.00064222445,0.0010788844],"domain_scores_gemma":[0.9921737,0.0016793715,0.004822033,0.00032961357,0.00024071353,0.0007545824],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0038411552,0.0005102441,0.002879387,0.0007196299,0.00035207183,0.000015166534,0.00037344484,0.0005135582,0.00008400256],"category_scores_gemma":[0.00021826326,0.0003771424,0.00016403278,0.0006187829,0.00008234855,0.00022435917,0.0001954256,0.004325453,0.000017083907],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000013961144,0.00020601899,0.03649344,0.028150035,0.00020462893,0.00017654563,0.0002929425,3.3093428e-7,6.5277777e-7,0.000049432023,0.00020094792,0.9342111],"study_design_scores_gemma":[0.0009688784,0.00043673156,0.0015694179,0.011532772,0.00054340455,0.00034965045,0.002168508,0.0000048277757,0.0000022778631,0.0000117437785,0.9821327,0.00027909345],"about_ca_topic_score_codex":0.28269497,"about_ca_topic_score_gemma":0.65778375,"teacher_disagreement_score":0.98193175,"about_ca_system_score_codex":0.016342148,"about_ca_system_score_gemma":0.052050117,"threshold_uncertainty_score":0.99986804},"labels":[],"label_agreement":null},{"id":"W2089635679","doi":"10.1155/2013/812387","title":"Intranasal, siRNA Delivery to the Brain by TAT/MGF Tagged PEGylated Chitosan Nanoparticles","year":2013,"lang":"en","type":"article","venue":"Journal of Pharmaceutics","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; McGill University","keywords":"Nasal administration; Biodistribution; Pharmacology; In vivo; Medicine; Toxicity; Chitosan; Blood–brain barrier; Small interfering RNA; Neurodegeneration; Chemistry; Central nervous system; In vitro; Internal medicine; Transfection; Biology; Biochemistry; Biotechnology","score_opus":0.015586439982732098,"score_gpt":0.2872528425984473,"score_spread":0.2716664026157152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089635679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886568,0.0018989681,0.00064817484,0.008043685,0.0004095176,0.00017680839,0.000015281179,0.0000055018486,0.00014526707],"genre_scores_gemma":[0.99193597,0.0009599636,0.00020805714,0.0061764796,0.0004538315,0.0000055327505,0.000009134435,0.000020459414,0.0002305866],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99878234,0.00012464213,0.00042319766,0.00015351678,0.00022392403,0.00029239414],"domain_scores_gemma":[0.99911857,0.00003307878,0.00019838648,0.00020331879,0.0002227227,0.00022395041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025806733,0.00016331006,0.00016780072,0.00005280466,0.000097762495,0.00008236593,0.00045970397,0.00008921055,0.00011037979],"category_scores_gemma":[0.00008597189,0.00011322969,0.00013337897,0.00012871198,0.000062986364,0.000017682416,0.000089726425,0.00024369631,0.000054697623],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000989925,0.00006608927,0.00020112518,0.0000049095697,0.000123165,0.0000048907314,0.00014785402,0.000313317,0.85348105,0.0000019235954,0.13660811,0.008948552],"study_design_scores_gemma":[0.0005887188,0.00044699543,0.0002936363,0.000017193328,0.00004765834,0.000056193505,0.0002830886,0.0002584716,0.9141976,0.000018588664,0.08364663,0.00014519317],"about_ca_topic_score_codex":0.000016168502,"about_ca_topic_score_gemma":0.000008579996,"teacher_disagreement_score":0.060716555,"about_ca_system_score_codex":0.000012374456,"about_ca_system_score_gemma":0.00007689437,"threshold_uncertainty_score":0.46173728},"labels":[],"label_agreement":null}]}